Can a patient on chronic hemodialysis safely undergo a technetium‑99m‑methylene diphosphonate (Tc‑99m‑MDP) bone scan, and how should the scan be timed relative to dialysis sessions?

Hemodialysis Patients Can Safely Undergo Tc-99m-MDP Bone Scans Without Special Timing Considerations

Patients on chronic hemodialysis can safely undergo Tc-99m-MDP bone scans without requiring specific timing relative to dialysis sessions, as the radiotracer is not significantly removed by dialysis and provides valuable diagnostic information for bone pathology common in this population. 1, 2

Safety and Feasibility

• Tc-99m-MDP bone scanning is not limited by the presence of dialysis or renal failure, making it a practical imaging option for hemodialysis patients 1
• The radiotracer behaves as a weak chelate that binds to bone mineral and is not efficiently cleared by hemodialysis 3
• No special precautions or timing adjustments relative to dialysis sessions are required in the available literature 1, 2

Clinical Utility in Dialysis Patients

Bone scans provide particularly valuable diagnostic information in hemodialysis patients due to their high prevalence of bone pathology:

• Renal osteodystrophy can be differentiated using bone scan patterns: decreased tracer uptake indicates dialysis-related osteomalacia, while increased uptake suggests secondary hyperparathyroidism or osteitis fibrosa 4
• Dialysis-related amyloidosis (beta-2-microglobulin type) shows increased tracer uptake at articular and periarticular regions, often preceding radiologically visible changes 5
• Insufficiency fractures, which occur more frequently in dialysis patients with metabolic bone disease, are readily detected on bone scan 6

Diagnostic Performance

• Whole-body retention of Tc-99m diphosphonate at 24 hours is significantly elevated in renal osteodystrophy patients (mean 88.6%) compared to normal individuals (mean 19.2%), providing quantitative diagnostic information 7
• The semi-quantitative assessment of bone tracer uptake reliably distinguishes between different types of renal bone disease in hemodialysis patients 4
• Bone scans can detect early osteoarticular changes in dialysis patients before conventional radiographs show abnormalities 5

Practical Considerations

• Standard bone scan protocols apply: imaging is typically performed 2-4 hours after Tc-99m-MDP injection, when approximately 40-50% of the injected dose has localized to bone 3
• Three-phase bone scanning (flow, blood pool, and delayed phases) can provide additional diagnostic information for differentiating acute processes like infection from chronic bone disease 1, 8
• The radiation exposure from bone scanning (approximately 4.6 mGy fetal dose early in pregnancy, 1.8 mGy at 9 months) is within acceptable diagnostic ranges 9

Common Pitfalls to Avoid

• Do not assume that renal failure will prevent adequate bone imaging—skeletal uptake occurs independently of renal clearance 4, 3
• Recognize that increased bone uptake in dialysis patients may reflect underlying metabolic bone disease rather than metastatic disease or infection 4
• Be aware that bone scan findings must be interpreted in the clinical context, as patterns differ between dialysis-related osteomalacia (decreased uptake) and secondary hyperparathyroidism (increased uptake) 4